Sea4Market: Clinical validation of a novel non-opioid analgesic derived from the Portuguese sea for treating ch...
SEA4US BIOTECNOLOGIA E RECURSOS MARINHOS S.A.
tramitó un
HORIZON EUROPE:
HORIZON-EIC-2023-ACCELERATOR-01
Sea4Us is a world-class biotechnology company with a focus on translating marine-derived compounds with therapeutic potential for unmet medi...
2024-02-12 - 2026-02-28 | Financiado
2024-02-12 - 2026-02-28 | Financiado
Algae4IBD: ALGAE4IBD FROM NATURE TO BEDSIDE ALGAE BASED BIO COMPOUND FOR PREVENTION AND TREATMENT OF INFLAMMA...
SEA4US BIOTECNOLOGIA E RECURSOS MARINHOS S.A.
participó en un
H2020:
H2020-FNR-2020
Algae4IBD's mission is to develop commercial products for Inflammatory Bowel Disease (IBD) prevention and treatment using aquatic natural bi...
2021-05-03 - 2025-05-31 | Financiado
2021-05-03 - 2025-05-31 | Financiado
Sea4Pain: Development of a novel analgesic for chronic pain from marine derived compounds
SEA4US BIOTECNOLOGIA E RECURSOS MARINHOS S.A.
tramitó un
H2020:
H2020-EIC-SMEInst-2018-2020
"The Sea4Pain project will expand and define the development strategy for Sea4Us’s Drug Discovery and Development Platform – a platform that...
2018-05-02 - 2018-09-30 | Financiado
2018-05-02 - 2018-09-30 | Financiado
Ocean Medicines: Ocean Medicines
SEA4US BIOTECNOLOGIA E RECURSOS MARINHOS S.A.
participó en un
H2020:
H2020-MSCA-RISE-2015
Marine organisms have the capacity to produce a variety of biologically potent natural products. Such novel molecules have new mechanisms of...
2015-10-13 - 2019-11-30 | Financiado
2015-10-13 - 2019-11-30 | Financiado
* No se disponen de datos de la empresa actual.